Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ INVESTOR DEADLINE AUGUST 25: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity... (PR Newswire) +++ SAREPTA Aktie +5,13%

News zum Sektor Gesundheit aus Mexiko

Zum Sektor Gesundheit gehören Unternehmen der Pharmaka- & Biotechnologiebranche, Produzenten von medizintechnischen Geräten, Gesundheitsdienste, Kliniken und Pflegeeinrichtungen.
 >Gesundheit ETFs & Fonds 
Es sind 100 ETFs & Fonds zum Sektor Gesundheit bekannt.
 >Aktien zum Sektor Gesundheit 
Es sind 1576 Aktien zum Sektor Gesundheit bekannt.
 
20.08.25 - 14:36
Santhera signs deal with Uniphar for GCC distribution of Agamree (PBR)
 
The therapy is intended for the treatment of Duchenne muscular dystrophy (DMD) in patients aged four years and above. Sales are projected to begin on a named patient The post Santhera signs deal with Uniphar for GCC distribution of Agamree appeared first on Pharmaceutical Business review....
19.08.25 - 07:03
Santhera schließt Vereinbarung mit Uniphar über den Vertrieb von AGAMREE® (Vamorolon) in fünf Ländern des Golf-Kooperationsrats (GCC) (GlobeNewswire)
 
Pratteln, Schweiz, 19. August 2025 – Santhera Pharmaceuticals (SIX: SANN) gibt die Unterzeichnung einer exklusiven Vereinbarung mit Uniphar über den Vertrieb von AGAMREE® (Vamorolon) in den Vereinigten Arabischen Emiraten, Saudi-Arabien, Kuwait, Oman und Bahrain zur Behandlung von Duchenne-Muskeldystrophie (DMD) bei Patienten ab vier Jahren bekannt....
24.07.25 - 01:12
Genomma Lab Internacional Announces Results for the Second Quarter 2025 (PR Newswire)
 
MEXICO CITY, July 23, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the second quarter of 2025. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance......
08.07.25 - 15:54
Inogen Alliance: How Terra Nexus Applies ′Building With Nature′ in Large-Scale GCC Projects (Accesswire)
 
NORTHAMPTON, MA / ACCESS Newswire / July 8, 2025 / Nivine Issa, Managing Director, Terra NexusAs cities and infrastructure rapidly expand across the globe, the need to rethink how we build has neve......
03.07.25 - 15:30
Fresenius Medical Care To Extend Access To HighVolumeHDF Dialysis Therapy In Mexico (AFX)
 
BAD HOMBURG VOR DER HOEHE (dpa-AFX) - Fresenius Medical Care AG (FMS), a company focused on kidney-related products and services, said on Thursday that it will extend High-Volume Hemodiafiltration......
24.06.25 - 00:45
GENOMMA LAB INTERNACIONAL ANNOUNCES TWELFTH DIVIDEND PAYMENT (PR Newswire)
 
MEXICO CITY, June 23, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, informs that the Company filed a......
12.06.25 - 17:36
GENOMMA LAB INTERNATIONAL INFORMS TOTAL PREPAYMENT OF "LAB 23" UNSECURED LOCAL BOND (CEBUR) (PR Newswire)
 
MEXICO CITY, June 12, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of Mexico's leading pharmaceutical and personal care companies with a growing international footprint, announced that on June 11, 2025, it completed the......
04.06.25 - 15:33
Genomma Lab successfully issued the LAB 25 and LAB 25-2 unsecured bonds (Cebures) for a total amount of $1.2 billion pesos, which will be used to prepay liabilities, including the full early amortization of the LAB 23 bond (PR Newswire)
 
The 6- and 7-year tranches were oversubscribed by 1.25 times the total amount offered MEXICO CITY, June 4, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in......
01.05.25 - 00:54
Genomma Lab Internacional Announces Results for the First Quarter 2025 (PR Newswire)
 
MEXICO CITY, April 30, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2025. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance......
20.04.25 - 17:30
In The Holiday Shortened Easter Week, These Large-Cap Stock Were Top Performers (Apr 14-Apr 18): Are These In Your Portfolio? (Benzinga)
 
Top performers last week: ServiceTitan, Summit Therapeutics, YPF, Eli Lilly, MicroStrategy, America Movil, Ericsson, Insmed, Diamondback, Neurocrine Biosciences. read more...
11.04.25 - 10:18
OncoZenge enters licensing agreement with Avernus Pharma for BupiZenge™ in the GCC Region (Cision)
 
OncoZenge AB (publ) [”OncoZenge” or the "Company”] announces that the Company and Avernus Pharma General Trading LLC (“Avernus”), a pharma marketing company from the UAE, have signed an exclusive agreement to license BupiZenge™ (Bupivacaine oral lozenges) for commercialization and distribution in the Gulf Cooperation Council (GCC) region. Background The licensing agreement entails that Avernus will be the exclusive distributor of BupiZenge™ in the GCC region, including Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the UAE, pending successful completion of the BupiZenge™ phase 3 trial and...
01.04.25 - 00:24
Genomma Lab Internacional S.A.B. de C.V. First Quarter 2025 Earnings Results Conference Call (PR Newswire)
 
MEXICO CITY, March 31, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its First Quarter 2025 Earnings Results on Wednesday, April 30, 2025, after the Mexican Stock Exchange (BMV) close. The......
11.03.25 - 16:18
EQL Pharma signs a distribution agreement with a large distributor in the GCC countries for Mellozzan (melatonin) (Cision)
 
EQL has entered into an exclusive distribution agreement with Pharmalink for its product Mellozzan (melatonin) for the GCC (Gulf Cooperation Council) region comprising of United Arab Emirates, Saudi Arabia, Kuwait, Qatar, Oman and Bahrain. "EQL has previously signed many agreements with parties for EU territories, but this is a milestone as it is our first agreement with the sale of one of our products outside the borders of Europe," says Axel Schörling, CEO at EQL Pharma. Mellozzan contains the sleep hormone melatonin and is indicated for children who have ADHD and suffer from sleep...
06.03.25 - 22:48
GENOMMA LAB INTERNACIONAL ANNOUNCES ELEVENTH DIVIDEND PAYMENT (PR Newswire)
 
MEXICO CITY, March 6, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, informs that the Company filed a......
03.03.25 - 18:27
Pentagon Deploys Mechanized Infantry And Air Support To Secure Mexico Border, Including Team Of 4,400 Soldiers (ZeroHedge)
 
Pentagon Deploys Mechanized Infantry And Air Support To Secure Mexico Border, Including Team Of 4,400 Soldiers The Pentagon is deploying a Stryker Brigade Combat Team and a General Support Aviation Battalion to the southwestern border, accelerating efforts to fulfill President Trump's directive to bolster military support in securing the U.S. – Mexico border. The units, equipped with wheeled vehicle and air capabilities, are set to reinforce border operations in the coming weeks, Pentagon Press Secretary Sean Parnell announced over the weekend. Each SBCT is a mechanized infantry force of approximately 4,400 soldiers, and the Army's nine SBCTs — seven active-duty and two National Guard — are known for their rapid deployment and versatility. Built around the Stryker vehicle — an eight-wheeled armored platform — the brigade balances mobility, protection and firepower. Capable of transport via C-130 Hercules aircraft within 96 hours, the Stryker excels in operations requiring swift res...
27.02.25 - 01:12
Genomma Lab Internacional Announces Results for the Fourth Quarter and Full Year 2024 (PR Newswire)
 
MEXICO CITY, Feb. 26, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the fourth quarter and full year ended December 31, 2024. All figures included herein are stated in nominal Mexican pesos and......
31.01.25 - 23:31
Trump: USA werden ab Mitte Februar Zölle auf Computerchips, Stahl sowie Öl- und Gasimporte erheben (Dow Jones)
 
Die USA werden ab Mitte Februar Zölle auf Computerchips, Pharmazeutika, Stahl, Aluminium, Kupfer sowie Öl- und Gasimporte erheben, sagte Präsident Donald Trump am Freitag und eröffnete damit eine neue Front in den bevorstehenden Handelskonflikten für die zweite Amtszeit. "Das wird ziemlich bald passieren", sagte Trump zu Reportern im Oval Office und fügte hinzu, dass er auch die Zölle für die Europäische Union erhöhen möchte. Er spezifizierte allerdings nicht, ab wann diese gelten oder wie hoch die Zölle ausfallen werden.. --- Die geplanten US-Zölle gegen Mexiko, Kanada und China werden am Samstag eingeführt, so die Sprecherin des Weißen Hauses, Karoline Leavitt am Freitag. US-Präsident Trump plane Zölle von 25 Prozent gegen Kanada und Mexiko und in Höhe von 10 Prozent gegen China, sagte Leavitt. Trump deutete am Donnerstag an, dass einige Waren, wie Öl, ausgenommen sein könnten, sagte jedoch am Freitag, dass Öl stattdessen einen reduzierten Zoll von etwa 10 Prozent haben könnte..
13.01.25 - 15:30
Cosmos Health Inc.: Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries (Accesswire)
 
CHICAGO, IL / ACCESSWIRE / January 13, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative......
05.12.24 - 02:24
Eisai And Biogen: Mexico Approves LEQEMBI For Early Alzheimer′s Disease Treatment (AFX)
 
WESTON (dpa-AFX) - Eisai Co., Ltd. (ESALF.PK) and Biogen Inc. (BIIB) announced that the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) in Mexico has approved humanized anti......
20.11.24 - 15:02
Leader Life Sciences Inks Deal To Distribute Bio-Techne′s Portfolio Of Products Across GCC Countries (AFX)
 
WASHINGTON (dpa-AFX) - Life sciences company Bio-Techne Corp. (TECH) announced Wednesday a partnership with Leader Life Sciences under which Leader Life Sciences will become a distributor of Bio-T......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Das nackte Kind, das zagt nicht; mit seinem Pfennig springt es fort und kennt recht gut den Sammelort - ich meine des Bäckers Laden. - Johann Wolfgang von Goethe
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!